Identification of germline cancer predisposition variants during clinical ctDNA testing
Abstract Next-generation sequencing of circulating tumor DNA (ctDNA) is a non-invasive method to guide therapy selection for cancer patients. ctDNA variant allele frequency (VAF) is commonly reported and may aid in discerning whether a variant is germline or somatic. We report on the fidelity of VAF...
Guardado en:
Autores principales: | Leigh Anne Stout, Nawal Kassem, Cynthia Hunter, Santosh Philips, Milan Radovich, Bryan P. Schneider |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0cc58bca3e134f00802d49538b3886c5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Heterozygous APC germline mutations impart predisposition to colorectal cancer
por: Livia Preisler, et al.
Publicado: (2021) -
Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits
por: Solip Park, et al.
Publicado: (2018) -
Rational design of on-chip gold plasmonic nanoparticles towards ctDNA screening
por: Amogha Tadimety, et al.
Publicado: (2021) -
Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
por: Bin Qiu, et al.
Publicado: (2021) -
MCM9 is associated with germline predisposition to early-onset cancer—clinical evidence
por: Yael Goldberg, et al.
Publicado: (2021)